{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:12:19Z","timestamp":1790305939998,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS093057"],"award-info":[{"award-number":["R01NS093057"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reddy Lee Family Moyamoya Research Fund"},{"name":"Moyamoya & Angiogenesis Research Fund"},{"name":"Bernard and Ronni Lacroute"},{"DOI":"10.13039\/100000933","name":"William Randolph Hearst Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000933","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Moyamoya disease (MMD) is a chronic cerebrovascular disorder that can lead to stroke and neurological dysfunctions. Given the largely sporadic nature and the role of gene-environment interactions in various diseases, we examined epigenetic modifications in MMD. We performed genome-wide DNA methylation using Illumina 850\u00a0K Methylation EPIC BeadChip, in two racially distinct adult female cohorts: a non-Asian cohort (13 MMD patients and 7 healthy controls) and an Asian cohort (14 MMD patients and 3 healthy controls). An additional external cohort with both sexes (females: 5 MMD patients and 5 healthy controls, males: 5 MMD patients and 5 healthy controls) was included for validation. Our findings revealed strikingly low DNA methylation variability between MMD patients and healthy controls, in both MMD female cohorts. In the non-Asian cohort, only 6 probes showed increased variability versus 647 probes that showed decreased variability. Similarly, in the Asian cohort, the MMD group also displayed a reduced methylation variability across all 2845 probes. Subsequent analysis showed that these differentially variable probes are located on genes involved in key biological processes such as methylation and transcription, DNA repair, cytoskeletal remodeling, natural killer cell signaling, cellular growth, and migration. These findings mark the first observation of low methylation variability in any disease, contrasting with the high variability observed in other disorders. This reduced methylation variability in MMD may hinder patients\u2019 adaptability to environmental shifts, such as hemodynamic stress, thereby influencing vascular homeostasis and contributing to MMD pathology. These findings offer new insights into the mechanisms of MMD and potential treatment strategies.<\/jats:p>","DOI":"10.1007\/s12975-024-01299-w","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T08:02:12Z","timestamp":1727856132000},"page":"1198-1213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Kikutaro","family":"Tokairin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary K.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"1299_CR1","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3171\/2011.3.FOCUS1151","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Arnaout OM, Rahme RJ, et al. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus. 2011;30:E20.","journal-title":"Neurosurg Focus"},{"key":"1299_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399.","journal-title":"Arch Neurol"},{"key":"1299_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3171\/2011.3.FOCUS1151","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Arnaout OM, Rahme RJ, et al. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus. 2011;30:20.","journal-title":"Neurosurg Focus"},{"key":"1299_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/STROKEAHA.107.490714","volume":"39","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39:42\u20137.","journal-title":"Stroke"},{"key":"1299_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34\u201340.","journal-title":"J Hum Genet"},{"issue":"7","key":"1299_CR6","doi-asserted-by":"publisher","first-page":"22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6(7):22542.","journal-title":"PLoS One"},{"issue":"3","key":"1299_CR7","first-page":"1977","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease (Review). Exp Ther Med. 2019;17(3):1977\u201384.","journal-title":"Exp Ther Med"},{"key":"1299_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000345957","volume":"40","author":"D Kainth","year":"2013","unstructured":"Kainth D, Chaudhry SA, Kainth H, et al. Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology. 2013;40:282\u20137.","journal-title":"Neuroepidemiology"},{"key":"1299_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaneurol.2021.1681","volume":"78","author":"AJ Kundishora","year":"2021","unstructured":"Kundishora AJ, Peters ST, Pinard A, et al. DIAPH1 variants in non\u2013East Asian Patients with sporadic moyamoya disease. JAMA Neurol. 2021;78:993\u20131003.","journal-title":"JAMA Neurol"},{"key":"1299_CR10","first-page":"49","volume":"8","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D. Kossorotoff M Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49\u201368.","journal-title":"Appl Clin Genet"},{"key":"1299_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","volume":"13","author":"R Mertens","year":"2022","unstructured":"Mertens R, Graupera M, Gerhardt H, et al. The genetic basis of moyamoya disease. Transl Stroke Res. 2022;13:25\u201345.","journal-title":"Transl Stroke Res"},{"key":"1299_CR12","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337.","journal-title":"N Engl J Med"},{"key":"1299_CR13","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1161\/01.STR.0000100159.43123.D7","volume":"34","author":"SK Kim","year":"2003","unstructured":"Kim SK, Il Yoo J, Cho BK, et al. Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease. Stroke. 2003;34:2835\u201341.","journal-title":"Stroke"},{"key":"1299_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, et al. Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1299_CR15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A, et al. Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol. 2009;72:476\u201380.","journal-title":"Surg Neurol"},{"key":"1299_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12975-023-01135-7","volume":"15","author":"K Abhinav","year":"2023","unstructured":"Abhinav K, Lee AG, Pendharkar AV, et al. Comprehensive profiling of secreted factors in the cerebrospinal fluid of moyamoya disease patients. Transl Stroke Res. 2023;15:399\u2013408.","journal-title":"Transl Stroke Res"},{"key":"1299_CR17","doi-asserted-by":"publisher","first-page":"e0163561","DOI":"10.1371\/journal.pone.0163561","volume":"11","author":"S Hamauchi","year":"2016","unstructured":"Hamauchi S, Shichinohe H, Uchino H, et al. Cellular functions and gene and protein expression profiles in endothelial cells derived from moyamoya disease-specific iPS cells. PLoS One. 2016;11:e0163561.","journal-title":"PLoS One"},{"key":"1299_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3171\/2013.9.JNS131000","volume":"120","author":"HS Kang","year":"2014","unstructured":"Kang HS, Moon YJ, Kim YY, et al. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model. J Neurosurg. 2014;120:415\u201325.","journal-title":"J Neurosurg"},{"issue":"8","key":"1299_CR19","first-page":"e0221911","volume":"14","author":"X Peng","year":"2019","unstructured":"Peng X, Zhang Z, Ye D, et al. Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders. PLoS One. 2019;14(8):e0221911.","journal-title":"PLoS One"},{"key":"1299_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-023-02781-8","volume":"18","author":"Q Tang","year":"2023","unstructured":"Tang Q, Li W, Huang J, et al. Single-cell sequencing analysis of peripheral blood in patients with moyamoya disease. Orphanet J Rare Dis. 2023;18:1\u201312.","journal-title":"Orphanet J Rare Dis"},{"key":"1299_CR21","doi-asserted-by":"publisher","first-page":"7192060","DOI":"10.1155\/2022\/7192060","volume":"2022","author":"S He","year":"2022","unstructured":"He S, Ye X, Duan R, et al. Epigenome-wide association study reveals differential methylation sites and association of gene expression regulation with ischemic moyamoya disease in adults. Oxid Med Cell Longev. 2022;2022:7192060.","journal-title":"Oxid Med Cell Longev"},{"key":"1299_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrg1655","volume":"6","author":"KD Robertson","year":"2005","unstructured":"Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6:597\u2013610.","journal-title":"Nat Rev Genet"},{"key":"1299_CR23","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","volume":"76","author":"M Klutstein","year":"2016","unstructured":"Klutstein M, Nejman D, Greenfield R, Cedar H. DNA methylation in cancer and aging. Cancer Res. 2016;76:3446\u201350.","journal-title":"Cancer Res"},{"key":"1299_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.atherosclerosis.2015.05.001","volume":"241","author":"BJ Toghill","year":"2015","unstructured":"Toghill BJ, Saratzis A, Harrison SC, et al. The potential role of DNA methylation in the pathogenesis of abdominal aortic aneurysm. Atherosclerosis. 2015;241:121\u20139.","journal-title":"Atherosclerosis"},{"key":"1299_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","volume":"8","author":"RG Urdinguio","year":"2009","unstructured":"Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 2009;8:1056\u201372.","journal-title":"Lancet Neurol"},{"key":"1299_CR26","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/ijms21062220","volume":"21","author":"O Mart\u00ednez-Iglesias","year":"2020","unstructured":"Mart\u00ednez-Iglesias O, Carrera I, Carril JC, et al. DNA methylation in neurodegenerative and cerebrovascular disorders. Int J Mol Sci. 2020;21:2220.","journal-title":"Int J Mol Sci"},{"key":"1299_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/STROKEAHA.118.023436","volume":"50","author":"Y Shen","year":"2019","unstructured":"Shen Y, Peng C, Bai Q, et al. Epigenome-wide association study indicates hypomethylation of MTRNR2L8 in large-artery atherosclerosis stroke. Stroke. 2019;50:1330\u20138.","journal-title":"Stroke"},{"key":"1299_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12864-018-4618-9","volume":"19","author":"D Palumbo","year":"2018","unstructured":"Palumbo D, Affinito O, Monticelli A, Cocozza S. DNA methylation variability among individuals is related to CpGs cluster density and evolutionary signatures. BMC Genomics. 2018;19:229.","journal-title":"BMC Genomics"},{"key":"1299_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s13059-014-0465-4","volume":"15","author":"B Phipson","year":"2014","unstructured":"Phipson B, Oshlack A. DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging. Genome Biol. 2014;15:465.","journal-title":"Genome Biol"},{"key":"1299_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-018-0575-9","volume":"10","author":"AP Webster","year":"2018","unstructured":"Webster AP, Plant D, Ecker S, et al. Increased DNA methylation variability in rheumatoid arthritis-discordant monozygotic twins. Genome Med. 2018;10:64.","journal-title":"Genome Med"},{"key":"1299_CR31","doi-asserted-by":"publisher","first-page":"13555","DOI":"10.1038\/ncomms13555","volume":"7","author":"DS Paul","year":"2016","unstructured":"Paul DS, Teschendorff AE, Dang MAN, et al. Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nat Commun. 2016;7:13555.","journal-title":"Nat Commun"},{"key":"1299_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.865","volume":"43","author":"KD Hansen","year":"2011","unstructured":"Hansen KD, Timp W, Bravo HC, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet. 2011;43:768.","journal-title":"Nat Genet"},{"key":"1299_CR33","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3171\/2022.8.JNS22336","volume":"138","author":"M Teo","year":"2022","unstructured":"Teo M, Abhinav K, Bell-Stephens TE, et al. Short- and long-term outcomes of moyamoya patients post-revascularization. J Neurosurg. 2022;138:1374\u201384.","journal-title":"J Neurosurg"},{"key":"1299_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J, et al. Diagnostic criteria for moyamoya disease-2021 revised version. Neurol Med Chir. 2022;62:307\u201312.","journal-title":"Neurol Med Chir"},{"key":"1299_CR35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139.","journal-title":"Bioinformatics"},{"key":"1299_CR36","unstructured":"Benton MC Illumina450K_filtering: a collection of resources to filter Illumina 450k and EPIC methylation arrays"},{"key":"1299_CR37","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41592-018-0213-x","volume":"15","author":"SC Zheng","year":"2018","unstructured":"Zheng SC, Breeze CE, Beck S, Teschendorff AE. Identification of differentially methylated cell types in epigenome-wide association studies. Nat Methods. 2018;15:1059\u201366.","journal-title":"Nat Methods"},{"key":"1299_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, Zhang X, Huang CC, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinform. 2010;11:587.","journal-title":"BMC Bioinform"},{"key":"1299_CR39","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1299_CR40","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/bioinformatics\/bty892","volume":"35","author":"X Ren","year":"2019","unstructured":"Ren X, Kuan PF. methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics. 2019;35(11):1958\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/bty892.","journal-title":"Bioinformatics"},{"key":"1299_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"key":"1299_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/15592294.2015.1121362","volume":"10","author":"MA Song","year":"2015","unstructured":"Song MA, Brasky TM, Marian C, et al. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women. Epigenetics. 2015;10:1177\u201387.","journal-title":"Epigenetics"},{"key":"1299_CR43","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/bdra.20770","volume":"91","author":"RM Adkins","year":"2011","unstructured":"Adkins RM, Krushkal J, Tylavsky FA, Thomas F. Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res A Clin Mol Teratol. 2011;91:728\u201336.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"1299_CR44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4161\/epi.6.5.15335","volume":"6","author":"FF Zhang","year":"2011","unstructured":"Zhang FF, Cardarelli R, Carroll J, et al. Significant differences in global genomic DNA methylation by gender and race\/ethnicity in peripheral blood. Epigenetics. 2011;6:623\u20139.","journal-title":"Epigenetics"},{"key":"1299_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.expneurol.2014.09.017","volume":"268","author":"RJ Felling","year":"2015","unstructured":"Felling RJ. Song H Epigenetic mechanisms of neuroplasticity and the implications for stroke recovery. Exp Neurol. 2015;268:37\u201345.","journal-title":"Exp Neurol"},{"key":"1299_CR46","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1007\/s12035-016-9966-3","volume":"54","author":"X Li","year":"2016","unstructured":"Li X, Xiao B, Chen XS. DNA methylation: a new player in multiple sclerosis. Mol Neurobiol. 2016;54:4049\u201359.","journal-title":"Mol Neurobiol"},{"key":"1299_CR47","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15592294.2019.1588682","volume":"14","author":"A Henderson-Smith","year":"2019","unstructured":"Henderson-Smith A, Fisch KM, Hua J, et al. DNA methylation changes associated with Parkinson\u2019s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood. Epigenetics. 2019;14:365\u201382.","journal-title":"Epigenetics"},{"key":"1299_CR48","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/acel.12349","volume":"14","author":"MJ Jones","year":"2015","unstructured":"Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging Cell. 2015;14:924\u201332.","journal-title":"Aging Cell"},{"key":"1299_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2018.12.003","volume":"76","author":"Z Huo","year":"2019","unstructured":"Huo Z, Zhu Y, Yu L, et al. DNA methylation variability in Alzheimer\u2019s disease. Neurobiol Aging. 2019;76:35.","journal-title":"Neurobiol Aging"},{"key":"1299_CR50","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.120.14708","volume":"77","author":"JJ Reho","year":"2021","unstructured":"Reho JJ, Guo DF, Morgan DA, Rahmouni K. mTORC1 (mechanistic target of rapamycin complex 1) signaling in endothelial and smooth muscle cells is required for vascular function. Hypertension. 2021;77:594\u2013604.","journal-title":"Hypertension"},{"key":"1299_CR51","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1126\/science.270.5237.794","volume":"270","author":"DC Thomis","year":"1995","unstructured":"Thomis DC, Gurniak CB, Tivol E, et al. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 1995;270:794\u20137.","journal-title":"Science"},{"key":"1299_CR52","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1161\/ATVBAHA.121.316293","volume":"41","author":"YC Wang","year":"2021","unstructured":"Wang YC, Cai D, Cui XB, et al. Janus kinase 3 deficiency promotes vascular reendothelialization-brief report. Arterioscler Thromb Vasc Biol. 2021;41:2019\u201326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1299_CR53","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","volume":"72","author":"N Stopa","year":"2015","unstructured":"Stopa N, Krebs JE, Shechter D. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond. Cell Mol Life Sci. 2015;72:2041\u201359.","journal-title":"Cell Mol Life Sci"},{"key":"1299_CR54","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/life11101074","volume":"11","author":"A Motolani","year":"2021","unstructured":"Motolani A, Martin M, Sun M, Lu T. The structure and functions of PRMT5 in human diseases. Life. 2021;11:1074.","journal-title":"Life"},{"key":"1299_CR55","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.celrep.2018.08.002","volume":"24","author":"PJ Hamard","year":"2018","unstructured":"Hamard PJ, Santiago GE, Liu F, et al. PRMT5 regulates DNA repair by controlling the alternative splicing of histone-modifying enzymes. Cell Rep. 2018;24:2643\u201357.","journal-title":"Cell Rep"},{"key":"1299_CR56","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/s41467-018-04462-8","volume":"9","author":"R Piazza","year":"2018","unstructured":"Piazza R, Magistroni V, Redaelli S, et al. SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub. Nat Commun. 2018;9:2192.","journal-title":"Nat Commun"},{"key":"1299_CR57","doi-asserted-by":"publisher","first-page":"359069","DOI":"10.3389\/fimmu.2018.02191","volume":"9","author":"SA Apostolidis","year":"2018","unstructured":"Apostolidis SA, Stifano G, Tabib T, et al. Single cell RNA sequencing identifies HSPG2 and APLNR as markers of endothelial cell injury in systemic sclerosis skin. Front Immunol. 2018;9:359069.","journal-title":"Front Immunol"},{"key":"1299_CR58","doi-asserted-by":"publisher","first-page":"H337","DOI":"10.1152\/ajpheart.00654.2013","volume":"307","author":"L Gotha","year":"2014","unstructured":"Gotha L, Lim SY, Osherov AB, et al. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury. Am J Physiol Hear Circ Physiol. 2014;307:H337\u201345.","journal-title":"Am J Physiol Hear Circ Physiol"},{"key":"1299_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5853\/jos.2015.01760","volume":"18","author":"OY Bang","year":"2016","unstructured":"Bang OY, Fujimura M. Kim S-K The pathophysiology of moyamoya disease: an update. J Stroke. 2016;18:12\u201320.","journal-title":"J Stroke"},{"key":"1299_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1172-8-45","volume":"8","author":"TK Sigdel","year":"2013","unstructured":"Sigdel TK, Shoemaker LD, Chen R, et al. Immune response profiling identifies autoantibodies specific to moyamoya patients. Orphanet J Rare Dis. 2013;8:45.","journal-title":"Orphanet J Rare Dis"},{"key":"1299_CR61","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, et al. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28:939\u201350.","journal-title":"Trends Mol Med"},{"key":"1299_CR62","first-page":"14","volume":"81","author":"C Review","year":"2014","unstructured":"Review C, Communication S. Principles G World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14\u20138.","journal-title":"J Am Coll Dent"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-024-01299-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-024-01299-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-024-01299-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:02:55Z","timestamp":1750924975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-024-01299-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s12975-024-01299-w","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Stanford University School of Medicine (IRB-12625). The IRB operates under the Stanford Research Compliance Office (RCO), which provides support to the IRBs and ensures that all research conducted at Stanford adheres to ethical standards and regulatory requirements. This study was conducted in accordance with the World Medical Association Declaration of Helsinki (Ethical Principles for Medical Research Involving Human Subjects) [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided written informed consent for this study using documents approved by the Institutional Review Board of the Stanford University School of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Dr. Steinberg is a consultant for SanBio, Zeiss, Peter Lazic, US, and Surgical Theater.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}